Veru inc.'s oncology drug research program partner, the university of tennessee health science center, awarded two new federal grants

Research grants from u.s. department of defense (dod) and national cancer institute's research project grant (nci r01) awarded to uthsc to study new types of targeting agents for multiple cancer indications with significant unmet need
VERU Ratings Summary
VERU Quant Ranking